|
1
|
Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.
|
Life Sci
|
1983
|
1.00
|
|
2
|
Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice.
|
Life Sci
|
1984
|
0.85
|
|
3
|
Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative.
|
Eur J Pharmacol
|
1986
|
0.80
|
|
4
|
In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.
|
Eur J Pharmacol
|
1984
|
0.79
|
|
5
|
Relationships between plasma corticosteroids and benzodiazepines in stress.
|
J Pharmacol Exp Ther
|
1979
|
0.79
|
|
6
|
In vivo blockade of dopaminergic receptors from different rat brain regions by classical and atypical neuroleptics.
|
Biochem Pharmacol
|
1980
|
0.75
|
|
7
|
Central dopaminergic neurons during development of genetic and DOCA-salt hypertension in the rat.
|
Brain Res
|
1981
|
0.75
|
|
8
|
Evidence for an increase in [3H]spiperone binding in hypothalamic nuclei during the development of spontaneous hypertension in the rat.
|
Clin Exp Hypertens A
|
1983
|
0.75
|